Cephalon to bid $318 million for Arana Therapeutics

03/2/2009 | American City Business Journals

Cephalon said it plans to offer $318 million to acquire Arana Therapeutics, an Australian company that has "an established protein-engineering technology platform" for turning proteins into potent treatments. Cephalon said Arana's independent directors support the takeover offer and will recommend it to stockholders.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC